According to filings with the U.S. Securities and Exchange Commission, Pharmaceutics International is raising up to $8,249,990.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Joseph Kiely played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Pharmaceutics International
Pharmaceutics International, Inc. (Pii) Concept-to-Clinic-to-Commercialization Pharmaceutics Know-How. Pharmaceutics International, Inc. (Pii) is a science-driven contract development and manufacturing organization (CDMO) located in Hunt Valley, MD, USA, offering unparalleled scientific insight and depth of product knowledge to supply high-quality dosage forms that enhance the lives of patients worldwide. Founded in 1994, Pii has grown from 12 employees to more than 270 scientists and support staff. With more than 360,000 square feet of operating space, Piis cGMP and DEA-registered facilities are state-of-the-art. More than 70 manufacturing suites include containment areas for handling high potency compounds and hormones, dedicated manufacturing suites for oral products (e.g., soft gels) and injectables (e.g., vials, syringes, cartridges), a formulation development center, and analytical and micro laboratories.

To learn more about Pharmaceutics International, visit http://www.pharm-int.com/
Company Linkedin Page: https://www.linkedin.com/company/pharmaceutics-international/

Contact:
Joseph Kiely, Chief Financial Officer
410-584-0001
https://www.linkedin.com/in/joe-kiely-bb94b06/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.